The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial by Aleksandr D. Kulagin, Bulat A. Bakirov, Igor L. Davydkin, Ilya V. Elykomov, Tatiana S. Konstantinova, Aleksandr V. Korobkin, Marina V. Kosinova, Vadim I. Mazurov, Natalia V. Minaeva, Andrei V. Proidakov, Vadim V. Ptushkin, Yuri V. Shatokhin, Yulia N. Lin'kova, Arina V. Zinkina-Orikhan, Maria A. Morozova

Get full text